日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Channelopathy-causing mutations in the S(45)A/S(45)B and HA/HB helices of K(Ca)2.3 and K(Ca)3.1 channels alter their apparent Ca(2+) sensitivity

K(Ca)2.3 和 K(Ca)3.1 通道的 S(45)A/S(45)B 和 HA/HB 螺旋中的通道病致病突变会改变其表观 Ca2+ 敏感性。

Orfali, Razan; Nam, Young-Woo; Nguyen, Hai Minh; Rahman, Mohammad Asikur; Yang, Grace; Cui, Meng; Wulff, Heike; Zhang, Miao

Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways

放射性核素刺激动态疗法正交靶向破骨细胞和骨髓瘤细胞诱导多维细胞死亡途径

Alexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, Julie Prior, Xiaoxia Yang, Grace Cui, Baogang Xu, Steven Fletcher, Francesca Fontana, Gregory Lanza, Samuel Achilefu

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

VLA4 靶向纳米粒子劫持细胞粘附介导的耐药性,以靶向难治性骨髓瘤细胞并延长生存期

Francesca Fontana, Michael J Scott, John S Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan, Noriko Yanaba, Mark A Fiala, Julie O'Neal, Anne H Schmieder-Atteberry, Julie Ritchey, Michael Rettig, Kathleen Simons, Steven Fletcher, Ravi Vij, John F DiPersio, Gregory M Lanza

Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer

c-myc 抑制剂的纳米疗法靶向乳腺癌中的促肿瘤巨噬细胞并保留抗肿瘤巨噬细胞

Alison K Esser, Michael H Ross, Francesca Fontana, Xinming Su, Ariel Gabay, Gregory C Fox, Yalin Xu, Jingyu Xiang, Anne H Schmieder, Xiaoxia Yang, Grace Cui, Michael Scott, Samuel Achilefu, Jay Chauhan, Steven Fletcher, Gregory M Lanza, Katherine N Weilbaecher

Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer

放射性核素将化疗药物转化为光疗法,用于精准治疗播散性癌症

Nalinikanth Kotagiri, Matthew L Cooper, Michael Rettig, Christopher Egbulefu, Julie Prior, Grace Cui, Partha Karmakar, Mingzhou Zhou, Xiaoxia Yang, Gail Sudlow, Lynne Marsala, Chantiya Chanswangphuwana, Lan Lu, LeMoyne Habimana-Griffin, Monica Shokeen, Xinming Xu, Katherine Weilbaecher, Michael Toma

Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy

利用荧光寿命成像和超分辨率显微镜研究 Sn-2 磷脂酰胆碱前药的细胞运输

Dolonchampa Maji, Jin Lu, Pinaki Sarder, Anne H Schmieder, Grace Cui, Xiaoxia Yang, Dipanjan Pan, Matthew D Lew, Samuel Achilefu, Gregory M Lanza

Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model

αvβ3 靶向 Sn2 脂肪酶不稳定的烟曲霉素前药纳米粒子和唑来膦酸在 Vx2 兔肿瘤模型中的双重治疗

Alison K Esser, Anne H Schmieder, Michael H Ross, Jingyu Xiang, Xinming Su, Grace Cui, Huiying Zhang, Xiaoxia Yang, John S Allen, Todd Williams, Samuel A Wickline, Dipanjan Pan, Gregory M Lanza, Katherine N Weilbaecher

Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers

混合锰-钆纳米胶体中表面和核心包裹金属之间的协同作用可实现更安全的稀疏生物标志物 MRI 成像

Kezheng Wang, Dipanjan Pan, Anne H Schmieder, Angana Senpan, Dennis E Hourcade, Christine T N Pham, Lynne M Mitchell, Shelton D Caruthers, Grace Cui, Samuel A Wickline, Baozhong Shen, Gregory M Lanza

Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury

抗凝血酶纳米粒子改善肾脏再灌注并保护缺血再灌注损伤后的肾功能

Junjie Chen, Chandu Vemuri, Rohun U Palekar, Joseph P Gaut, Matthew Goette, Lingzhi Hu, Grace Cui, Huiying Zhang, Samuel A Wickline

Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles

使用 α(v)β₃ 靶向治疗诊断纳米粒子,通过脂肪酶可裂解的 Sn2 紫杉烷磷脂前药对 Vx2 兔癌模型进行抗血管生成治疗

Dipanjan Pan, Anne H Schmieder, Kezheng Wang, Xiaoxia Yang, Angana Senpan, Grace Cui, Kendall Killgore, Benjamin Kim, John S Allen, Huiying Zhang, Shelton D Caruthers, Baozhong Shen, Samuel A Wickline, Gregory M Lanza